Global Bioprinting 麻豆原创 Research Report 2024

Publication ID:

PB508243295

Publication Date:

August 23, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Bioprinting is an advanced form of 3D printing that involves the creation of biological structures using cells, growth factors, and biomaterials, often referred to as bio-inks. This technology has the potential to revolutionize medicine by enabling the fabrication of complex tissue structures, and potentially even entire organs, for use in medical research, drug testing, and regenerative medicine.
The global Bioprinting market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
The market for 3D bioink and bioprinting is experiencing rapid growth due to its potential to revolutionize healthcare and regenerative medicine. This technology has applications in drug testing, disease modeling, and ultimately, the generation of functional human organs for transplantation. The market is driven by increased investments in research and development, collaborations between biotechnology companies and academic institutions, and a growing demand for personalized medicine. North America, Europe, and Asia-Pacific are the leading regions in terms of market adoption, with major players in the bioprinting industry continuously innovating and expanding their product portfolios.
This report aims to provide a comprehensive presentation of the global market for Bioprinting, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioprinting.
The Bioprinting market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bioprinting market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bioprinting companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
EnvisionTEC GmbH
Aspect Biosystems Ltd.
Regenovo Biotechnology Co., Ltd.
regenHU
GeSiM
CELLINK
Cyfuse Biomedical K.K.
ROKIT Healthcare
TeVido BioDevices
Advanced Solutions Life Sciences
Organovo Holdings Inc.
Allevi Inc.
Poietis
Nano3D Biosciences, Inc.
Digilab Inc
Segment by Type
Bio-inks
Bioprinters
3D Models
Segment by Application
Research Application
Clinical Application
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioprinting company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Bioprinting 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bio-inks
1.2.3 Bioprinters
1.2.4 3D Models
1.3 麻豆原创 by Application
1.3.1 Global Bioprinting 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Application
1.3.3 Clinical Application
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioprinting 麻豆原创 Perspective (2019-2030)
2.2 Global Bioprinting Growth Trends by Region
2.2.1 Global Bioprinting 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bioprinting Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Bioprinting Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Bioprinting 麻豆原创 Dynamics
2.3.1 Bioprinting Industry Trends
2.3.2 Bioprinting 麻豆原创 Drivers
2.3.3 Bioprinting 麻豆原创 Challenges
2.3.4 Bioprinting 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioprinting Players by Revenue
3.1.1 Global Top Bioprinting Players by Revenue (2019-2024)
3.1.2 Global Bioprinting Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Bioprinting 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bioprinting Revenue
3.4 Global Bioprinting 麻豆原创 Concentration Ratio
3.4.1 Global Bioprinting 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioprinting Revenue in 2023
3.5 Global Key Players of Bioprinting Head office and Area Served
3.6 Global Key Players of Bioprinting, Product and Application
3.7 Global Key Players of Bioprinting, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioprinting Breakdown Data by Type
4.1 Global Bioprinting Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Bioprinting Forecasted 麻豆原创 Size by Type (2025-2030)
5 Bioprinting Breakdown Data by Application
5.1 Global Bioprinting Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Bioprinting Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Bioprinting 麻豆原创 Size (2019-2030)
6.2 North America Bioprinting 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bioprinting 麻豆原创 Size by Country (2019-2024)
6.4 North America Bioprinting 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bioprinting 麻豆原创 Size (2019-2030)
7.2 Europe Bioprinting 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bioprinting 麻豆原创 Size by Country (2019-2024)
7.4 Europe Bioprinting 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bioprinting 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Bioprinting 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bioprinting 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Bioprinting 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bioprinting 麻豆原创 Size (2019-2030)
9.2 Latin America Bioprinting 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bioprinting 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Bioprinting 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioprinting 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Bioprinting 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bioprinting 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Bioprinting 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 EnvisionTEC GmbH
11.1.1 EnvisionTEC GmbH Company Details
11.1.2 EnvisionTEC GmbH Business Overview
11.1.3 EnvisionTEC GmbH Bioprinting Introduction
11.1.4 EnvisionTEC GmbH Revenue in Bioprinting Business (2019-2024)
11.1.5 EnvisionTEC GmbH Recent Development
11.2 Aspect Biosystems Ltd.
11.2.1 Aspect Biosystems Ltd. Company Details
11.2.2 Aspect Biosystems Ltd. Business Overview
11.2.3 Aspect Biosystems Ltd. Bioprinting Introduction
11.2.4 Aspect Biosystems Ltd. Revenue in Bioprinting Business (2019-2024)
11.2.5 Aspect Biosystems Ltd. Recent Development
11.3 Regenovo Biotechnology Co., Ltd.
11.3.1 Regenovo Biotechnology Co., Ltd. Company Details
11.3.2 Regenovo Biotechnology Co., Ltd. Business Overview
11.3.3 Regenovo Biotechnology Co., Ltd. Bioprinting Introduction
11.3.4 Regenovo Biotechnology Co., Ltd. Revenue in Bioprinting Business (2019-2024)
11.3.5 Regenovo Biotechnology Co., Ltd. Recent Development
11.4 regenHU
11.4.1 regenHU Company Details
11.4.2 regenHU Business Overview
11.4.3 regenHU Bioprinting Introduction
11.4.4 regenHU Revenue in Bioprinting Business (2019-2024)
11.4.5 regenHU Recent Development
11.5 GeSiM
11.5.1 GeSiM Company Details
11.5.2 GeSiM Business Overview
11.5.3 GeSiM Bioprinting Introduction
11.5.4 GeSiM Revenue in Bioprinting Business (2019-2024)
11.5.5 GeSiM Recent Development
11.6 CELLINK
11.6.1 CELLINK Company Details
11.6.2 CELLINK Business Overview
11.6.3 CELLINK Bioprinting Introduction
11.6.4 CELLINK Revenue in Bioprinting Business (2019-2024)
11.6.5 CELLINK Recent Development
11.7 Cyfuse Biomedical K.K.
11.7.1 Cyfuse Biomedical K.K. Company Details
11.7.2 Cyfuse Biomedical K.K. Business Overview
11.7.3 Cyfuse Biomedical K.K. Bioprinting Introduction
11.7.4 Cyfuse Biomedical K.K. Revenue in Bioprinting Business (2019-2024)
11.7.5 Cyfuse Biomedical K.K. Recent Development
11.8 ROKIT Healthcare
11.8.1 ROKIT Healthcare Company Details
11.8.2 ROKIT Healthcare Business Overview
11.8.3 ROKIT Healthcare Bioprinting Introduction
11.8.4 ROKIT Healthcare Revenue in Bioprinting Business (2019-2024)
11.8.5 ROKIT Healthcare Recent Development
11.9 TeVido BioDevices
11.9.1 TeVido BioDevices Company Details
11.9.2 TeVido BioDevices Business Overview
11.9.3 TeVido BioDevices Bioprinting Introduction
11.9.4 TeVido BioDevices Revenue in Bioprinting Business (2019-2024)
11.9.5 TeVido BioDevices Recent Development
11.10 Advanced Solutions Life Sciences
11.10.1 Advanced Solutions Life Sciences Company Details
11.10.2 Advanced Solutions Life Sciences Business Overview
11.10.3 Advanced Solutions Life Sciences Bioprinting Introduction
11.10.4 Advanced Solutions Life Sciences Revenue in Bioprinting Business (2019-2024)
11.10.5 Advanced Solutions Life Sciences Recent Development
11.11 Organovo Holdings Inc.
11.11.1 Organovo Holdings Inc. Company Details
11.11.2 Organovo Holdings Inc. Business Overview
11.11.3 Organovo Holdings Inc. Bioprinting Introduction
11.11.4 Organovo Holdings Inc. Revenue in Bioprinting Business (2019-2024)
11.11.5 Organovo Holdings Inc. Recent Development
11.12 Allevi Inc.
11.12.1 Allevi Inc. Company Details
11.12.2 Allevi Inc. Business Overview
11.12.3 Allevi Inc. Bioprinting Introduction
11.12.4 Allevi Inc. Revenue in Bioprinting Business (2019-2024)
11.12.5 Allevi Inc. Recent Development
11.13 Poietis
11.13.1 Poietis Company Details
11.13.2 Poietis Business Overview
11.13.3 Poietis Bioprinting Introduction
11.13.4 Poietis Revenue in Bioprinting Business (2019-2024)
11.13.5 Poietis Recent Development
11.14 Nano3D Biosciences, Inc.
11.14.1 Nano3D Biosciences, Inc. Company Details
11.14.2 Nano3D Biosciences, Inc. Business Overview
11.14.3 Nano3D Biosciences, Inc. Bioprinting Introduction
11.14.4 Nano3D Biosciences, Inc. Revenue in Bioprinting Business (2019-2024)
11.14.5 Nano3D Biosciences, Inc. Recent Development
11.15 Digilab Inc
11.15.1 Digilab Inc Company Details
11.15.2 Digilab Inc Business Overview
11.15.3 Digilab Inc Bioprinting Introduction
11.15.4 Digilab Inc Revenue in Bioprinting Business (2019-2024)
11.15.5 Digilab Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

EnvisionTEC GmbH
Aspect Biosystems Ltd.
Regenovo Biotechnology Co., Ltd.
regenHU
GeSiM
CELLINK
Cyfuse Biomedical K.K.
ROKIT Healthcare
TeVido BioDevices
Advanced Solutions Life Sciences
Organovo Holdings Inc.
Allevi Inc.
Poietis
Nano3D Biosciences, Inc.
Digilab Inc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.